openPR Logo
Press release

Ocular Pain Market Share and Growth Factors Impact Analysis 2014 - 2020

03-14-2018 10:06 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Ocular Pain Market Share and Growth Factors Impact Analysis 2014

Ocular pain is also known as eye pain that occurs on the surface of the eye. Ocular pain is considered as a common medical condition that resolves on its own but, sometimes it creates emergency medical conditions. Possible causes for ocular pain includes corneal discomfort, pain in the sclera and discomfort in conjunctiva and pain in the iris. Moreover, few other etiology of ocular pain includes pain in extracellular muscle of the eye, burning sensation in nerves present in the eye and paining sensation on the eyelids.

Sinusitis, migraines, traumatic events and glaucoma are considered as few of medical conditions that can cause ocular pain. possible signs and symptoms of ocular pain includes pain in the eye, partial loss of vision, light sensitivity, double vision, halos vision, severe headache, irregularly shaped pupil, bulging eye and blood inside the front of eye. Common test utilized for diagnosis of ocular pain includes slit-lamp exam, dilating drops test and tonometer test. Medications used for the treatment of ocular pain include antibacterial medications, antiviral medications and steroids.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2718

Increasing unhygienic lifestyle among population is considered as a major market driving factor for the global ocular pain treatment market because bacterial and viral ocular infections are primarily observed among people with unhygienic lifestyle. Moreover, increasing awareness among people about eye related diseases would further accentuate the market growth in few developed nations of the world.

Technological advancement in diagnostic test and increasing disposable income among population is also considered as a market driving factor of ocular pain treatment. However, lack of awareness and proper healthcare facilities present in few of the developing nations is considered as a factor that might restrict the global market demand of ocular pain treatment.

North America and Europe was observed to be the largest ocular pain treatment market due to major market players are based in these regions. Moreover, technological advancement in diagnostic test and strong demand of diagnostic test would also account for the market growth in these regions. In addition, favorable initiative taken by the federal government also accounted for the ocular pain treatment market growth in North American and European regions. Increasing awareness among people about eye related diseases and its precautions is also considered as market deriving factor in North American and European regions.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2718

Similarly, Asia-Pacific is considered as an untapped market due to lack of proper diagnostic facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget).

Similarly, Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Increasing disposable income among population is also accounted for the ocular pain treatment market growth in Asia-Pacific countries. Rest of the world (RoW) holds fourth position in the global ocular pain treatment market due to poor economic and health condition in most of the African countries. RoW market growth will be fuelled by extensive increase in healthcare infrastructure in Brazil and Mexico.

Some of the major players in the Ocular Pain Market are Sylentis S.A., Bayer AG, InSite Vision Incorporated, Reata Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., Bristol Meyer Squibb, Merck and Co. among others.

Obtain Report Details @ https://www.transparencymarketresearch.com/ocular-pain-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocular Pain Market Share and Growth Factors Impact Analysis 2014 - 2020 here

News-ID: 977822 • Views:

More Releases from Transparency Market Research

Global Coal Market Outlook 2036: Industry to Reach US$ 2,558.8 Billion by 2036 Driven by Energy Demand, Infrastructure Expansion, and HELE Technology Adoption
Global Coal Market Outlook 2036: Industry to Reach US$ 2,558.8 Billion by 2036 D …
The global coal market was valued at US$ 1,595.1 Bn in 2025 and is projected to reach US$ 2,558.8 Bn by 2036, expanding at a CAGR of 4.4% from 2026 to 2036. The industry continues to remain a cornerstone of global energy systems, particularly in emerging economies where coal-fired power generation supports industrialization and infrastructure growth. Asia Pacific dominated the global coal market in 2025, accounting for 83.0% of total revenue
Metalworking Fluids Market Expanding at 3.7% CAGR Through 2036 - By Type / By Application / By End-use | U.S. • China • Germany • India
Metalworking Fluids Market Expanding at 3.7% CAGR Through 2036 - By Type / By Ap …
The global metalworking fluids market was valued at US$ 11.8 Bn in 2025 and is projected to reach US$ 17.6 Bn by 2036, expanding at a steady CAGR of 3.7% during the forecast period from 2026 to 2036. The market's moderate yet stable growth trajectory reflects its strong integration into essential industrial operations across automotive, aerospace, construction, marine, medical, and heavy engineering sectors. Get a concise overview of key insights from
Bio-based Epoxy Resin Market to Reach US$ 11.5 Billion by 2036 Amid Sustainability Push
Bio-based Epoxy Resin Market to Reach US$ 11.5 Billion by 2036 Amid Sustainabili …
The global bio-based epoxy resin market is entering a transformative growth phase as industries shift toward sustainable and low-carbon material solutions. Valued at US$ 6.4 billion in 2025, the market is projected to reach US$ 11.5 billion by 2036, expanding at a CAGR of 5.5% from 2026 to 2036. Increasing regulatory pressure, evolving sustainability mandates, and the growing adoption of renewable raw materials are accelerating demand across multiple end-use industries. Bio-based
Plant Growth Regulators Market to Reach US$ 11.97 Billion by 2036, Driven by Rising Demand for Agricultural Productivity and Expansion of High-Value Crops | Latest Report TMR
Plant Growth Regulators Market to Reach US$ 11.97 Billion by 2036, Driven by Ris …
The global plant growth regulators market was valued at US$ 7,569.9 Mn in 2025 and is projected to reach US$ 11,971.1 Mn by 2036, expanding at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2036. Market growth is primarily driven by rising pressure to improve agricultural productivity and the rapid expansion of high-value crops and protected cultivation systems worldwide. Access key findings and insights from our Report in

All 5 Releases


More Releases for Ocular

How the Ocular Pain Market Is Growing in 2025 | What's New Treatments Are Coming …
According to the IMARC Group, the ocular pain market is expected to exhibit a CAGR of 7.66% during 2025-2035. This can be attributed to the growing use of services in teleophthalmology, which facilitates remote consultations and enhances patient adherence. Ocular pain is the discomfort or distress experienced within or around the eye. The ocular pain market is experiencing significant growth driven by multiple factors. Primarily, the increasing prevalence of conditions such
Key Influencer in the Ocular Implants Market 2025: Growing Geriatric Population …
What market dynamics are playing a key role in accelerating the growth of the ocular implants market? The growth of the ocular implants market is foreseen to be driven by the global increase in the geriatric population. The term 'geriatric population' is specifically used to refer to individuals aged 65 years or above. Ocular implants offer a solution to age-specific eye ailments prevalent among the elderly, such as cataracts, glaucoma, and
Neuropathic Ocular Pain Market Is Booming Worldwide 2025-2032 | OKYO Pharma, Lim …
Latest Report, titled "Neuropathic Ocular Pain Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Neuropathic Ocular Pain market has been
Neuropathic Ocular Pain Market Detailed In New Research Report 2024 |OKYO Pharma …
A recent report from Coherent Market Insight titled "Neuropathic Ocular Pain Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031" presents a thorough examination of the industry landscape, offering insights into market analysis and trends. Alongside competitor and regional analysis, the report delves into contemporary advancements within the market. Global Neuropathic Ocular Pain market is estimated to be valued at US$ 197.1 million in 2023 and is expected to
Ocular Neuropathic Pain Market to witness Robust Expansion by 2031 - OKYO Pharma …
Ocular neuropathic pain (ONP) is chronic eye pain caused by nerve damage or dysfunction. It can result from various conditions, such as corneal nerve injury, ocular surgeries, infections, or systemic diseases like diabetes. Patients experience persistent, burning, or stabbing eye pain, often without visible signs of inflammation. Diagnosis involves detailed patient history, clinical examination, and sometimes specialized tests. Treatment focuses on managing pain and may include topical or systemic medications,
Ocular Implant Market - Redefining Ophthalmic Solutions: Choose Ocular Implants …
Newark, New Castle, USA: The "Ocular Implant Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ocular Implant Market: https://www.growthplusreports.com/report/ocular-implant-market/7864 This latest report researches the industry structure, sales, revenue,